Pentraxin  	Pentraxin  	 NNP	B-NP
3  	3  	 CD	O
serum  	serum  	 CD	B-NP
levels  	levels  	 NNS	I-NP
in  	in  	 IN	O
children  	children  	 NNS	O
with  	with  	 IN	O
atopic  	atopic  	 FW	B-NP
dermatitis  	dermatitis  	 FW	I-NP
PTX3  	PTX3  	 FW	I-NP
behaves  	behaves  	 FW	O
as  	as  	 IN	O
an  	an  	 DT	O
acute-phase  	acute-phase  	 JJ	B-NP
response  	response  	 NN	I-NP
protein  	protein  	 NN	I-NP
as  	as  	 IN	O
its  	its  	 PRP$	O
blood  	blood  	 NN	O
levels  	levels  	 NNS	O
rapidly  	rapidly  	 RB	O
and  	and  	 CC	O
dramatically  	dramatically  	 RB	O
increase  	increase  	 VB	O
during  	during  	 IN	O
endotoxic  	endotoxic  	 JJ	B-NP
shock 	shock 	 NN	I-NP
,  	,  	 ,	O
sepsis 	sepsis 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
other  	other  	 JJ	O
inflammatory  	inflammatory  	 NN	O
and  	and  	 CC	O
infectious  	infectious  	 JJ	B-NP
conditions 	conditions 	 NNS	I-NP
.  	.  	 .	O
Therefore 	Therefore 	 RB	O
,  	,  	 ,	O
this  	this  	 DT	O
study  	study  	 NN	O
was  	was  	 VBD	O
designed  	designed  	 VBN	O
to  	to  	 TO	O
investigate  	investigate  	 VB	O
a  	a  	 DT	O
possible  	possible  	 JJ	O
role  	role  	 NN	O
of  	of  	 IN	O
PTX3  	PTX3  	 CD	B-NP
in  	in  	 IN	O
children  	children  	 NNS	O
with  	with  	 IN	O
Atopic  	Atopic  	 NNP	B-NP
Dermatitis  	Dermatitis  	 NNP	I-NP
( 	( 	 -LRB-	O
AD 	AD 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
One-hundred-and-thirty-six  	One-hundred-and-thirty-six  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
( 	( 	 -LRB-	O
37  	37  	 CD	O
females 	females 	 NNS	O
,  	,  	 ,	O
99  	99  	 CD	O
males 	males 	 NNS	O
,  	,  	 ,	O
mean  	mean  	 JJ	O
age  	age  	 NN	O
10.4  	10.4  	 CD	O
years 	years 	 NNS	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
enrolled  	enrolled  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
study 	study 	 NN	O
.  	.  	 .	O
One  	One  	 CD	O
hundred  	hundred  	 CD	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
74 	74 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
had  	had  	 VBD	O
only  	only  	 RB	O
respiratory  	respiratory  	 JJ	B-NP
symptoms  	symptoms  	 NNS	I-NP
( 	( 	 -LRB-	O
allergic  	allergic  	 JJ	B-NP
rhinitis  	rhinitis  	 NN	I-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
bronchial  	bronchial  	 JJ	B-NP
asthma 	asthma 	 NN	I-NP
) 	) 	 -RRB-	O
;  	;  	 :	O
thirty-six  	thirty-six  	 JJ	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
26 	26 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
showed  	showed  	 VBD	O
dermatitis  	dermatitis  	 VBN	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
respiratory  	respiratory  	 JJ	B-NP
allergy  	allergy  	 NN	I-NP
( 	( 	 -LRB-	O
allergic  	allergic  	 JJ	B-NP
rhinitis  	rhinitis  	 NN	I-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
bronchial  	bronchial  	 JJ	B-NP
asthma 	asthma 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
PTX3  	PTX3  	 NNP	B-NP
levels  	levels  	 NNS	I-NP
were  	were  	 VBD	O
higher  	higher  	 JJR	O
in  	in  	 IN	O
children  	children  	 NNS	O
with  	with  	 IN	O
AD  	AD  	 NNP	O
and  	and  	 CC	O
there  	there  	 EX	O
was  	was  	 VBD	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
correlation  	correlation  	 NN	O
between  	between  	 IN	O
serum  	serum  	 CD	B-NP
PTX3  	PTX3  	 CD	I-NP
levels  	levels  	 NNS	I-NP
and  	and  	 CC	O
SCORAD  	SCORAD  	 NNP	B-NP
index  	index  	 NN	I-NP
( 	( 	 -LRB-	O
p-value=0.0001 	p-value=0.0001 	 NNP	B-NP
,  	,  	 ,	O
rho=0.658 	rho=0.658 	 CD	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Therefore 	Therefore 	 RB	O
,  	,  	 ,	O
this  	this  	 DT	O
study  	study  	 NN	O
may  	may  	 MD	O
show  	show  	 VB	O
that  	that  	 IN	O
PTX3  	PTX3  	 NNP	B-NP
might  	might  	 MD	O
be  	be  	 VB	O
a  	a  	 DT	O
reliable  	reliable  	 JJ	O
marker  	marker  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
severity  	severity  	 NN	O
of  	of  	 IN	O
AD  	AD  	 NNP	O
in  	in  	 IN	O
children  	children  	 NNS	O
with  	with  	 IN	O
respiratory  	respiratory  	 JJ	B-NP
allergy 	allergy 	 NN	I-NP
.  	.  	 .	O
